PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Surgical Oncology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. Electronic address: Hamidiad@mums.ac.ir.\', \'Department of Anaesthesiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.\', \'Anaesthesiology and Critical Care Lung Research Center, Faculty of Medicine, Mashhad, Iran.\', \'Cancer Molecular Pathology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.\', \'ICU Department, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran.\', \'Research Committee, Faculty of Dentistry, Mashhad University of Medical Sciences, Mashhad, Iran.\', \'Department of Clinical Biochemistry, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.\', \'Department of Biochemistry, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0014-2999(20)30586-010.1016/j.ejphar.2020.173494
?:doi
?:hasPublicationType
?:journal
  • European journal of pharmacology
is ?:pmid of
?:pmid
?:pmid
  • 32828741
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.057
?:rankingScore_hIndex
  • 161
is ?:relation_isRelatedTo_publication of
?:title
  • Application of methylene blue -vitamin C -N-acetyl cysteine for treatment of critically ill COVID-19 patients, report of a phase-I clinical trial.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all